55.98 -1.09 (-1.92%)
JNJ
Stock Details
Last Trade:55.98 Change:-1.09 (-1.92%) Prev Close:57.07 Open: 56.73 Days Range:55.95 – 56.73 52 Week Range: 46.25 - 72.76 Volume:15119928 P/E: 12.25EPS:4.57
View AllRecent Alerts 07/03/09
Recent Alert on 07/02/09 at 12:11pm
Unusual 11 Mid-Day Movers 7/2: NAVI, AVNR, ESLR, ELN Higher; DSCO, SEPR, TIVO, ILMN Lower
Unusual 11 Mid-Day Movers 7/2: NAVI, AVNR, ESLR, ELN Higher; DSCO, SEPR, TIVO, ILMN Lower
Discovery Laboratories (Nasdaq: DSCO) 47% LOWER; Discovery Labs learned that the FDA will now apply a newly-defined standard to determine whether Discovery Labs has adequately demonstrated comparability of Surfaxin clinical to commercial drug... Read More
Recent Alert on 07/02/09 at 9:43am
Notable Mergers and Acquisitions of the Day 7/2: JNJ/ELN, FCSX/IAAC, LSTR
Notable Mergers and Acquisitions of the Day 7/2: JNJ/ELN, FCSX/IAAC, LSTR
Recent Alert on 07/02/09 at 9:32am
Morning Movers 7/2: ELN, QUIK, ESLR Higher; DSCO, LEA, SEPR, ILMN, MANH Lower
Morning Movers 7/2: ELN, QUIK, ESLR Higher; DSCO, LEA, SEPR, ILMN, MANH Lower
Recent Alert on 07/02/09 at 7:53am
Johnson & Johnson (JNJ) To Acquire Alzheimer's Assets From Elan (ELN), Invests $1B For 18.4% Stake
Johnson & Johnson (JNJ) To Acquire Alzheimer's Assets From Elan (ELN), Invests $1B For 18.4% Stake
Recent Alert on 07/02/09 at 7:53am
Johnson & Johnson (JNJ) To Acquire Alzheimer's Assets From Elan (ELN), Invests $1B For 18.4% Stake
Johnson & Johnson (JNJ) To Acquire Alzheimer's Assets From Elan (ELN), Invests $1B For 18.4% Stake
View AllRecent Press Releases
Press Release on 07/03/09 at 12:00pm
Cougar Biotechnology Announces Successful Completion of Johnson & Johnson's Initial Tender Offer and Commencement of Subsequent Offering Period
Cougar Biotechnology Announces Successful Completion of Johnson & Johnson's Initial Tender Offer and Commencement of Subsequent Offering Period
Press Release on 07/03/09 at 8:53am
Johnson & Johnson Completes Initial Tender Offer for Cougar Biotechnology
Johnson & Johnson Completes Initial Tender Offer for Cougar Biotechnology
Press Release on 07/02/09 at 7:57am
Johnson & Johnson and Elan Corporation plc Announce Definitive Agreement for Alzheimer's Immunotherapy Program and Equity Investment
Johnson & Johnson and Elan Corporation plc Announce Definitive Agreement for Alzheimer's Immunotherapy Program and Equity Investment
Press Release on 07/01/09 at 12:00pm
Video: Axel Ullrich Named Winner of 2009 Dr. Paul Janssen Award for Biomedical Research
Video: Axel Ullrich Named Winner of 2009 Dr. Paul Janssen Award for Biomedical Research
Press Release on 07/01/09 at 10:44am
2009 Winner of The Dr. Paul Janssen Award for Biomedical Research to be Announced at 6th Annual World Conference of Science Journalists
2009 Winner of The Dr. Paul Janssen Award for Biomedical Research to be Announced at 6th Annual World Conference of Science Journalists